Anthony C. Hooper
Director · BeOne Medicines Ltd.
- 2025
- Jun 15, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Anthony C. Hooper files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- John Oyler - $189.61M in ONC purchases and sales in the last 12 months
- Xiaodong Wang - $24.68M in ONC purchases and sales in the last 12 months
- Xiaobin Wu - $8.75M in ONC purchases and sales in the last 12 months
- Chan Henry Lee - $4.20M in ONC purchases and sales in the last 12 months
- Michael Castagna - $1.51M in MNKD purchases and sales in the last 12 months
- Lai Wang - $1.17M in ONC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Anthony C. Hooper?
Anthony C. Hooper is a corporate insider, tracked as Director of BeOne Medicines Ltd. (ONC). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Anthony C. Hooper last file a Form 4?
The most recent primary Form 4 on record is dated 15 June 2026, one of 5 filings going back to 2025.